Literature DB >> 2867948

The enzymatic systems involved in the mammalian metabolism of methylamine.

M S Dar, P L Morselli, E R Bowman.   

Abstract

The metabolism of methylamine has been investigated in the rat in order to elucidate the role of monoamine oxidase (MAO; EC 1.4.3.4) and intestinal bacteria in the metabolism of the compound. In a series of experiments in which short- and long-acting inhibitors of MAO were administered either alone or in combination prior to methyl-[14C]amine hydrochloride injection, the excretion of radioactivity in the expired air and the urine was examined to indirectly assess the role of MAO in the metabolism of methylamine. The data presented provide indirect evidence to demonstrate that the effect of iproniazid, an inhibitor of methylamine oxidation, is mediated through enzyme systems separate from MAO systems which have been invoked as major contributors to metabolism of methylamine by other investigators. The bacterial oxidation of methylamine in the intestine plays a minor role in the overall metabolism of the compound.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867948     DOI: 10.1016/0306-3623(85)90142-9

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  7 in total

1.  Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy.

Authors:  P H Yu; C T Lai; D M Zuo
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.

Authors:  M Unzeta; M Solé; M Boada; M Hernández
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

3.  Formaldehyde promotes and inhibits the proliferation of cultured tumour and endothelial cells.

Authors:  E Tyihák; J Bocsi; F Timár; G Rácz; B Szende
Journal:  Cell Prolif       Date:  2001-06       Impact factor: 6.831

4.  Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.

Authors:  P H Yu
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

5.  Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.

Authors:  R Pirisino; C Ghelardini; G Banchelli; N Galeotti; L Raimondi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype.

Authors:  Renato Pirisino; Carla Ghelardini; Alessandra Pacini; Nicoletta Galeotti; Laura Raimondi
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

Review 7.  SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.

Authors:  Mercedes Unzeta; Mar Hernàndez-Guillamon; Ping Sun; Montse Solé
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.